Gå ubegrenset med Magzter GOLD

Gå ubegrenset med Magzter GOLD

Få ubegrenset tilgang til over 9000 magasiner, aviser og premiumhistorier for bare

$149.99
 
$74.99/År

Prøve GULL - Gratis

Health

Chronicle Pharmabiz

Chromatography: Detecting volatile organic compounds

CHROMATOGRAPHY is a method or analytical process for separating mixtures based on differences in the speed at which they migrate over or through a stationary phase. This process can separate complex mixtures of chemicals or proteins into their various different components.

4 min  |

September 18, 2025

Chronicle Pharmabiz

Bulk drugs, intermediates imports grow 5 per cent

IMPORTS of bulk drugs and intermediates to India registered a growth of 5% in the month of July, 2025, while the cumulative imports for the first four months of the fiscal year witnessed a decline of 3.8%.

2 min  |

September 18, 2025
Chronicle Pharmabiz

Chronicle Pharmabiz

Gandhi Automations offers PRIME NEO for clean environment

GANDHI Automations Pvt Ltd, India's number one entrance automation and loading bay equipment company, offers multi-composites and highperformance door, PRIME NEO for clean environments.

1 min  |

September 18, 2025

Chronicle Pharmabiz

Healthcare shifts to patient-centric infra

THE healthcare sector in the country is undergoing a transformative shift, placing patients and sustainability at the heart of its infrastructure development. Hospitals and medical facilities across the country are increasingly adopting designs that prioritize patient comfort, healing environments, and eco-friendly operations.

2 min  |

September 18, 2025

Chronicle Pharmabiz

Tech to enhance various aspects of healthcare: Experts

INDIAN digital technology is placing engineers as the pivot of healthcare innovation and recognizing them as the fulcrum for transforming the future of medical care. Their expertise is crucial in integrating technology with healthcare systems, ensuring efficient, personalized, and scalable solutions that meet the evolving needs of the population.

1 min  |

September 18, 2025

Chronicle Pharmabiz

KPRDO opposes Abbott's move restricting distribution of Freestyle Libre

THE Karnataka Pharma Retailers & Distributors Organization (KPRDO) has reported a sharp increase in patient enquiries and concerns over the availability of Freestyle Libre sensors, following Abbott's recent decision to restrict distribution of the popular glucose monitoring device exclusively to online platforms.

2 min  |

September 18, 2025

Chronicle Pharmabiz

KEA to handle D Pharm seat allotment for govt, private quotas

KARNATAKA government has decided that seat allotment for D Pharmacy (D Pharm) courses from the academic year 2025-26 for both the government and private quota seats will be handled through the Karnataka Examinations Authority (KEA).

2 min  |

September 18, 2025

Chronicle Pharmabiz

CRC Press releases book on Ashwagandha

CRC Press, Taylor and Francis Group have released a dedicated book on Ashwagandha: Potential Drug Candidate from Ancient Ayurvedic Remedy. The editors are Dilip Ghosh and Benny Antony.

1 min  |

September 18, 2025

Chronicle Pharmabiz

Indian life sciences charts a pathway for AI-driven regulatory submissions

INDIAN life sciences sector is charting a transformative growth story, one that will position the country as a leader in Al-driven regulatory submissions and data standardization.

2 min  |

September 18, 2025

Chronicle Pharmabiz

'GST restructuring as a game-changing step'

THE Federation of Pharmaceutical Entrepreneurs (FOPE), Karnataka Drugs and Pharmaceutical Manufacturers Association (KDPMA), consultancy majors Grant Thornton Bharat and EY have underscored that the Union govť's move on GST restructuring is a game-changing step.

1 min  |

September 18, 2025

Chronicle Pharmabiz

Zydus announces results from EPICS-III phase 2(b)/3 trial

ZYDUS Therapeutics, a wholly owned subsidiary of Zydus Lifesciences Ltd., a global innovation led healthcare company, announced positive topline results from the pivotal EPICS-III phase 2(b)/3 clinical trial.

1 min  |

September 18, 2025
Chronicle Pharmabiz

Chronicle Pharmabiz

Telangana DCA raids quack's clinic in Nizamabad

TELANGANA Drug Control Administration (DCA) officials seized a stock of antibiotics and other medicines during a raid on the premises of a quack in Nizamabad district on September 10.

1 min  |

September 18, 2025

Chronicle Pharmabiz

Bulk drugs, intermediates exports grew 10% in July

EXPORTS of bulk drugs and intermediates grew almost 10 per cent in the month of July this year, while the exports growth was almost 6.6% for the first four months of the current fiscal year.

2 min  |

September 18, 2025

Chronicle Pharmabiz

Lupin, SUP ink pact to supply tiotropium DPI

GLOBAL pharma major Lupin Limited (Lupin) announced that it has signed a license and supply agreement with Sino Universal Pharmaceuticals (SUP), for the commercialization of tiotropium dry powder inhaler (DPI), 18 mcg/capsule, in the Chinese market, for the treatment of chronic obstructive pulmonary disease (COPD).

1 min  |

September 18, 2025

Chronicle Pharmabiz

Jharkhand DC issues norms on MRP revisions

In response to the Ministry of Consumer Affairs (MoCA) circular dated September 9, 2025, the drugs control department in Jharkhand has issued a formal directive allowing pharmaceutical and medical devices companies to revise maximum retail prices (MRP) on unsold stock in light of Goods and Services Tax (GST) rate changes.

1 min  |

September 18, 2025

Chronicle Pharmabiz

Mankind gets nod to begin phase 1 trials of MKP11093

MANKIND Pharma, India's 4th largest pharmaceutical company, has received approval from the Central Drugs Standard Control Organisation (CDSCO) to initiate a phase 1 clinical trial of MKP11093, a novel, orally administered Janus kinase-1 (JAK-1) inhibitor.

1 min  |

September 18, 2025

Chronicle Pharmabiz

Metal detector, cornerstone in quality management

IDENTIFYING the source of contamination and maintaining quality norms and standards of hygiene can help manufacture safe and quality products stipulated to government norms.

4 min  |

September 18, 2025

Chronicle Pharmabiz

Centre asked to decentralise Ayushman Bharat scheme

THE Parliamentary Panel on Finance has recommended that the health services under the Central government's flagship scheme Ayushman Bharat must be further decentralised using technology to address gaps in reach and accessibility.

2 min  |

September 18, 2025

Chronicle Pharmabiz

'Indian pharma to innovate generics to carve a global niche'

INDIAN pharma companies are moving away from merely supplying me-too versions of blockbuster drugs. Instead, these companies are increasingly leveraging the US FDA's 505(b)(2) regulatory pathway to create differentiated, value-added generics effectively carving a new global niche, said Dr Hemgir Gosavi, senior manager & centre head - Merck Formulation and Technology Centre, Merck Life Sciences.

2 min  |

September 18, 2025

Chronicle Pharmabiz

Formulations & biologicals exports grew 15.8% in July

EXPORTS of drug formulations and biologicals have gone up 15.85% during the month of July, 2025, while the cumulative growth of finished formulations and biologicals exports was at 7.66% for the first four months of the current fiscal year.

2 min  |

September 18, 2025

Chronicle Pharmabiz

'Industry needs to come out with proposals to utilise scheme funds'

WHILE the Central government has various kinds of schemes to support the medical devices industry, the industry may have to come out with good proposals so that the funds can be fully utilised, says Ravindra Pratap Singh, joint secretary, Department of Pharmaceuticals (DoP).

2 min  |

September 18, 2025

Chronicle Pharmabiz

RDCA asks industry for relief amid GST 2.0 transition challenges

WITH the rollout of GST 2.0 scheduled for September 22, 2025, the Retail Distribution Chemists Alliance (RDCA) in Delhi has raised serious concerns over the financial burden the transition will place on pharmaceutical distributors and retailers.

1 min  |

September 18, 2025

Chronicle Pharmabiz

Analytical techniques to identify metallic contaminants

METAL detectors play a vital role in detecting elemental impurities in pharmaceutical processing and production units.

4 min  |

September 18, 2025

Chronicle Pharmabiz

Botanic invests ₹25 cr for liposomal mfg unit

BOTANIC Healthcare, a global and nutraceutical innovation, has launched its dedicated liposomal manufacturing facility in Hyderabad with an investment of over Rs. 25 crore.

1 min  |

September 18, 2025

Chronicle Pharmabiz

SRK Group launches 'Kriam Pharma'

SHREE Ramkrishna Exports diamond industry, has taken a significant step into healthcare and holistic well-being with the launch of Kriam Pharma.

1 min  |

September 18, 2025

Chronicle Pharmabiz

analytica Lab India focuses on innovative solutions

EVEN as the laboratory world is developing rapidly, analytica Lab India, the largest and most important platform for the analysis, laboratory-technology and biotechnology market in India, stands as a testimony to the growing prowess of these sectors.

3 min  |

September 18, 2025

Chronicle Pharmabiz

NPPA extends price for IV fluids of 3 cos

THE National Pharmaceutical Pricing Authority (NPPA) has notified extension of separate ceiling price for several formulations and strengths of IV fluids manufactured by three companies, following its decision in a recent Authority meeting.

2 min  |

September 18, 2025

Chronicle Pharmabiz

Pharmaceuticals exports grow 5.2%

EXPORTS of drugs and pharEXPORTS of dr from the country registered around 5.2 per cent growth in the first three months of the fiscal year, from April to June, 2025, while imports reported a growth of 4.1 per cent, compared to the corresponding quarter of previous year.

1 min  |

September 18, 2025

Chronicle Pharmabiz

Maharashtra, powerhouse of Indian pharma industry

MAHARASHTRA, particularly the Mumbai-Pune corridor, is indisputably the powerhouse of the Indian pharmaceutical industry.

6 min  |

September 18, 2025

Chronicle Pharmabiz

AMMOI urges govt to exempt ayurvedic medicines from GST

THE Ayurveda Medicine Manufacturers Organisation of India (AMMOI) has appealed to Union finance minister Nirmala Sitharaman to revise the GST structure applicable to ayurvedic products.

1 min  |

September 18, 2025